CNS Metastases in Patients With RET Fusion–Positive NSCLC Treated With Selpercatinib
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Original article: Central nervous system disease in patients with RET fusion-positive non-small cell lung cancer treated with selpercatinib
J Thorac Oncol 2023 Jan 16;[EPub Ahead of Print], YR Murciano-Goroff, CJ Falcon, ST Lin, C Chacko, G Grimaldi, D Liu, C Wilhelm, A Iasonos, A DrilonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.